Xueyong Zhu

Citado por

	Total	Desde 2020
Citas	12039	7846
Índice h	50	37
Índice i10	81	70

2100

1050

525

1575

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202543 60 80 85 71 101 85 93 99 116 114 194 440 448 516 453 524 556 1273 2062 1721 1262 1198 313

Acceso público

Ver todo

66 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Meng YuanScripps Research InstituteDirección de correo verificada de scripps.edu
Nicholas C. WuUniversity of Illinois at Urbana-ChampaignDirección de correo verificada de illinois.edu
James PaulsonThe Scripps Research InstituteDirección de correo verificada de scripps.edu
Robert P de VriesDepartment of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical ScienceDirección de correo verificada de uu.nl
Sandhya BangaruStaff Scientist, The Scripps Research InstituteDirección de correo verificada de scripps.edu
Hannah L TurnerThe Scripps Research InstituteDirección de correo verificada de scripps.edu
Corwin NycholatThe Scripps Research InstituteDirección de correo verificada de scripps.edu
Maikun TengProfessor of School of Life Sciences, University of Science and Technology of ChinaDirección de correo verificada de ustc.edu.cn
James CroweVanderbilt University Medical CenterDirección de correo verificada de vanderbilt.edu
Netanel TzarumDepartment of Biological ChemistryThe Alexander Silberman Institute of Life SciencesFaculty ofDirección de correo verificada de mail.huji.ac.il
Andrew ThompsonCell Signaling TechnologyDirección de correo verificada de cellsignal.com
Rui XuJanssenDirección de correo verificada de its.jnj.com
Huibin LvUniversity of Illinois at Urbana-ChampaignDirección de correo verificada de illinois.edu
Chris Ka Pun MokThe Jockey Club School of Public Health and Primary Care, The Chinese University of Hong KongDirección de correo verificada de cuhk.edu.hk
Ray TY SoThe University of Hong KongDirección de correo verificada de hku.hk
Pavlo GilchukAstraZenecaDirección de correo verificada de astrazeneca.com
Wenjie PengShanghai Jiao Tong UniveristyDirección de correo verificada de sjtu.edu.cn
James StevensCenters for Disease Control and PreventionDirección de correo verificada de cdc.gov
William A Goddard IIIProfessor Chemistry, Materials Science, Applied PhysicsDirección de correo verificada de caltech.edu
Peter S. LeeAbbVieDirección de correo verificada de abbvie.com

Seguir

Xueyong Zhu

The Scripps Research Institute

Dirección de correo verificada de scripps.edu

Structural Biology Influenza Coronavirus Antibody


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
New world bats harbor diverse influenza A viruses S Tong, X Zhu, Y Li, M Shi, J Zhang, M Bourgeois, H Yang, X Chen, ... PLoS pathogens 9 (10), e1003657, 2013	1835	2013
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV M Yuan, NC Wu, X Zhu, CCD Lee, RTY So, H Lv, CKP Mok, IA Wilson Science 368 (6491), 630-633, 2020	1651	2020
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen A Impagliazzo, F Milder, H Kuipers, MV Wagner, X Zhu, RMB Hoffman, ... Science 349 (6254), 1301-1306, 2015	628	2015
Structural basis of a shared antibody response to SARS-CoV-2 M Yuan, H Liu, NC Wu, CCD Lee, X Zhu, F Zhao, D Huang, W Yu, Y Hua, ... Science 369 (6507), 1119-1123, 2020	600	2020
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants M Yuan, D Huang, CCD Lee, NC Wu, AM Jackson, X Zhu, H Liu, L Peng, ... Science 373 (6556), 818-823, 2021	378	2021
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape PA Koenig, H Das, H Liu, BM Kümmerer, FN Gohr, LM Jenster, ... Science 371 (6530), eabe6230, 2021	372	2021
Antibody catalysis of the oxidation of water P Wentworth Jr, LH Jones, AD Wentworth, X Zhu, NA Larsen, IA Wilson, ... Science 293 (5536), 1806-1811, 2001	371	2001
A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020	358	2020
Structural characterization of the 1918 influenza virus H1N1 neuraminidase X Xu, X Zhu, RA Dwek, J Stevens, IA Wilson Journal of virology 82 (21), 10493-10501, 2008	315	2008
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin NS Laursen, RHE Friesen, X Zhu, M Jongeneelen, S Blokland, J Vermond, ... Science 362 (6414), 598-602, 2018	236	2018
Broadly protective human antibodies that target the active site of influenza virus neuraminidase D Stadlbauer, X Zhu, M McMahon, JS Turner, TJ Wohlbold, AJ Schmitz, ... Science 366 (6464), 499-504, 2019	234	2019
A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface S Bangaru, S Lang, M Schotsaert, HA Vanderven, X Zhu, N Kose, ... Cell 177 (5), 1136-1152. e18, 2019	232	2019
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity H Liu, NC Wu, M Yuan, S Bangaru, JL Torres, TG Caniels, ... Immunity 53 (6), 1272-1280. e5, 2020	230	2020
Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic R Xu, X Zhu, R McBride, CM Nycholat, W Yu, JC Paulson, IA Wilson Journal of virology 86 (17), 9221-9232, 2012	215	2012
Hemagglutinin homologue from H17N10 bat influenza virus exhibits divergent receptor-binding and pH-dependent fusion activities X Zhu, W Yu, R McBride, Y Li, LM Chen, RO Donis, S Tong, JC Paulson, ... Proceedings of the National Academy of Sciences 110 (4), 1458-1463, 2013	203	2013
Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens P Wentworth Jr, AD Wentworth, X Zhu, IA Wilson, KD Janda, ... Proceedings of the National Academy of Sciences 100 (4), 1490-1493, 2003	174	2003
Preferential recognition of avian-like receptors in human influenza A H7N9 viruses R Xu, RP de Vries, X Zhu, CM Nycholat, R McBride, W Yu, JC Paulson, ... Science 342 (6163), 1230-1235, 2013	173	2013
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain NC Wu, M Yuan, H Liu, CCD Lee, X Zhu, S Bangaru, JL Torres, ... Cell reports 33 (3), 2020	168	2020
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection P Zhou, M Yuan, G Song, N Beutler, N Shaabani, D Huang, W He, X Zhu, ... Science translational medicine 14 (637), eabi9215, 2022	167	2022
Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors X Zhu, R McBride, CM Nycholat, W Yu, JC Paulson, IA Wilson Journal of virology 86 (24), 13371-13383, 2012	159	2012

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores